NEA Management Company, LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1512848
TIMONIUM, MD
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$186,153,611
+$59,615,309 QoQ
Shares Held
7,692,298
0.0% QoQ
Ownership
9.02%
of shares outstanding
% of Portfolio
11.72%
of 13F equity value
Holder Rank
#2
of 191 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. GLUE ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $246,594,552 | |
| 2 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $199,519,627 | |
| 3 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
7,692,298 | $186,153,611 | |
| 4 | CELC |
Celcuity Inc.
|
1,710,561 | $178,958,891 | |
| 5 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $164,552,620 | |
| 6 | SVRA |
Savara Inc
|
24,471,264 | $150,742,986 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $102,109,298 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,969,834 | $67,368,082 |
All Filings in GLUE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,153,611 | 7,692,298 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $126,538,302 | 7,692,298 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $120,615,232 | 7,692,298 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $56,999,928 | 7,692,298 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,692,263 | 7,692,298 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,692,262 | 7,692,298 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $53,384,548 | 7,692,298 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,769,179 | 7,692,298 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,769,194 | 7,692,298 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $54,230,700 | 7,692,298 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $43,461,483 | 7,692,298 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,846,107 | 7,692,298 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,692,241 | 7,692,298 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $59,923,001 | 7,692,298 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $58,538,387 | 7,692,298 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $62,935,184 | 7,703,205 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $74,489,992 | 7,703,205 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $107,998,934 | 7,703,205 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $157,299,446 | 7,703,205 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $171,627,407 | 7,703,205 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $174,862,753 | 7,703,205 | Shares | Defined | 2021-08-02 | |
| No filing history on record for this holder in this stock. | ||||||